test

ANDREW TIMPSON

@Silverarc Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -0.37%
0.87%
$3.858M
67,045 shares@ $57.54 avg price
MRSNMersana Therapeutics Inc
Recent Activity
Decreased -29.85%
0.75%
$3.315M
1.754M shares@ $1.9 avg price
SLDBSolid Biosciences Inc
Recent Activity
Decreased -3.22%
0.72%
$3.19M
457,739 shares@ $6.98 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Decreased -35.39%
0.51%
$2.243M
167,986 shares@ $13.35 avg price
TRVITrevi Therapeutics Inc
Recent Activity
Decreased -42.83%
0.37%
$1.612M
482,575 shares@ $3.35 avg price
KODKodiak Sciences Inc
Recent Activity
Decreased -52.92%
0.3%
$1.305M
500,000 shares@ $2.61 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Decreased -89.68%
0.09%
$367,214↑ Call
17,800 shares@ $20.63 avg price
VYNEVyne Therapeutics Inc
Recent Activity
Decreased -83.57%
0.04%
$144,354
76,784 shares@ $1.89 avg price